The Latest Regenerative Medicine Articles from Streetwise Reports


U.S. Biotech Makes 'The Acquisition We Were Waiting For'

Research Report
  ()
By tucking in this retinal gene therapy firm, the Massachusetts-based company gains assets and synergy. read more >

After Financing Close, Biotech's Subsidiary to Operate Independently

Research Report
  ()
An H.C. Wainwright & Co. report explained the purpose of the funding and how any resulting developments would positively impact the former parent company. read more >

Groundbreaking Biotech Company Takes Major Step Forward with Deal with Chinese Partner

  ()
Canada-based biotech company signs major deal with Chinese partner to advance groundbreaking technology in the skin and tendon rejuvenation space. read more >
Showing Results: 1 to 3 of 3

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"We expect PMN to forge a licensing deal in Q2/19 or Q3/19." ❭
– André Uddin, Mackie Research Capital
"VIV signed a partnership with CSA Animal Nutrition." ❭
– Alex Koyfman, First Call
"DRRX plans to respond to a complete response letter for Posimir." ❭
– Patrick Dolezal, LifeSci Capital